Ameritas Investment Partners, Inc. - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 52 filers reported holding ANAPTYSBIO INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$27,156
-11.7%
1,5120.0%0.00%0.0%
Q2 2023$30,754
-6.5%
1,5120.0%0.00%0.0%
Q1 2023$32,901
-13.4%
1,5120.0%0.00%
-50.0%
Q4 2022$37,997
-0.0%
1,5120.0%0.00%0.0%
Q3 2022$38,000
+26.7%
1,5120.0%0.00%
+100.0%
Q2 2022$30,000
-18.9%
1,5120.0%0.00%0.0%
Q1 2022$37,000
-30.2%
1,5120.0%0.00%
-50.0%
Q4 2021$53,000
+8.2%
1,512
-16.6%
0.00%0.0%
Q3 2021$49,000
+4.3%
1,8120.0%0.00%0.0%
Q2 2021$47,000
+20.5%
1,8120.0%0.00%
+100.0%
Q1 2021$39,000
-13.3%
1,812
-13.6%
0.00%
-50.0%
Q4 2020$45,000
+45.2%
2,0970.0%0.00%
+100.0%
Q3 2020$31,000
-34.0%
2,0970.0%0.00%
-50.0%
Q2 2020$47,000
+56.7%
2,0970.0%0.00%0.0%
Q1 2020$30,000
-11.8%
2,0970.0%0.00%0.0%
Q4 2019$34,000
-53.4%
2,0970.0%0.00%
-33.3%
Q3 2019$73,000
-38.1%
2,0970.0%0.00%
-40.0%
Q2 2019$118,000
-7.8%
2,097
+20.0%
0.01%
-16.7%
Q1 2019$128,000
+23.1%
1,748
+7.0%
0.01%0.0%
Q4 2018$104,000
-36.2%
1,6330.0%0.01%
-25.0%
Q3 2018$163,000
+40.5%
1,6330.0%0.01%
+33.3%
Q2 2018$116,000
-26.1%
1,633
+8.3%
0.01%
-25.0%
Q1 2018$157,000
+3.3%
1,5080.0%0.01%
+14.3%
Q4 2017$152,000
+1281.8%
1,508
+259.0%
0.01%
+600.0%
Q3 2017$11,000
+10.0%
4200.0%0.00%
Q2 2017$10,000
-16.7%
4200.0%0.00%
-100.0%
Q1 2017$12,0004200.00%
Other shareholders
ANAPTYSBIO INC shareholders Q2 2017
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,628,678$81,462,73111.84%
EcoR1 Capital, LLC 7,521,024$233,076,5347.09%
5AM Venture Management, LLC 357,733$11,086,1462.98%
Boxer Capital, LLC 1,300,000$40,287,0002.12%
Frazier Life Sciences Management, L.P. 899,700$27,881,7031.73%
Palo Alto Investors LP 431,024$13,357,4341.14%
Logos Global Management LP 250,000$7,747,5000.91%
BRAIDWELL LP 726,122$22,502,5210.75%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,161,826$36,004,9880.74%
Rock Springs Capital Management LP 576,600$17,868,8340.43%
View complete list of ANAPTYSBIO INC shareholders